clinical trial · NCT03494907
A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants
Janssen Research & Development, LLC·phase1·completed·n = 52
HealthySeltorexantPlacebo Matched to SeltorexantPlacebo Matched to MoxifloxacinMoxifloxacin Dose 1
brief summary
The purpose of this study is to assess the effects of single dose seltorexant on QT/QTc intervals and electrocardiogram (ECG) morphology at therapeutic and supratherapeutic exposures in healthy adult participants.
started
Apr 9, 2018
primary completion
Aug 13, 2018
completion
Aug 13, 2018
last updated
Apr 27, 2025
official title
A Randomized, Double-blind, Placebo- and Positive-controlled, Single-dose, 4-way Crossover Study to Evaluate the Effects of Seltorexant (JNJ-42847922) on Electrocardiogram Intervals in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol